Pacira BioSciences (PCRX) Amortizatization of Intangibles (2010 - 2026)

Pacira BioSciences (PCRX) recorded quarterly Amortizatization of Intangibles of $570000.0 in Q1 2026, down 88.19% quarter-over-quarter from $4.8 million in Q4 2025, and down 70.16% on a YoY basis from $1.9 million in Q1 2025.

Pacira BioSciences (PCRX) Amortizatization of Intangibles (2010 - 2026) Analysis & Trends

Pacira BioSciences' Amortizatization of Intangibles history runs 17 years deep, the most recent figure standing at $570000.0 for Q1 2026.

  • In Q1 2026, Amortizatization of Intangibles fell 70.16% year-over-year to $570000.0; the TTM figure through Mar 2026 stood at $5.5 million (down 41.17% YoY), while the FY2025 annual figure was $4.9 million, down 33.61% from the prior year.
  • Amortizatization of Intangibles was $570000.0 for Q1 2026 at Pacira BioSciences, down from $4.8 million in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $7.4 million in Q4 2024 to a low of $23000.0 in Q2 2024.
  • Historically, Amortizatization of Intangibles has averaged $1.3 million across 5 years, with a median of $675000.0 in 2023.
  • The sharpest annual moves came in 2024 and 2025: Amortizatization of Intangibles slumped 96.44% in 2024, then jumped 7858.33% in 2025.
  • A 5-year view of Amortizatization of Intangibles shows it stood at $700000.0 in 2022, then surged by 449.71% to $3.8 million in 2023, then surged by 91.03% to $7.4 million in 2024, then sank by 34.35% to $4.8 million in 2025, then plunged by 88.19% to $570000.0 in 2026.
  • The last three Amortizatization of Intangibles figures came in at $570000.0 (Q1 2026), $4.8 million (Q4 2025), and $56000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn -
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn -
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn -
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 1.30 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn -
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn -
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn -
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn 242,000.00
10 Pacira BioSciences 944.76 Mn 742.58 Mn 140.96 Mn 570,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 570,000.00
Mar 31, 2026 570,000.00
Dec 31, 2025 4.83 Mn
Dec 31, 2025 4.83 Mn
Sep 30, 2025 56,000.00
Sep 30, 2025 56,000.00
Jun 30, 2025 23,000.00
Jun 30, 2025 23,000.00
Mar 31, 2025 1.91 Mn
Mar 31, 2025 1.91 Mn
Dec 31, 2024 7.35 Mn
Dec 31, 2024 7.35 Mn
Sep 30, 2024 23,000.00
Sep 30, 2024 23,000.00
Jun 30, 2024 23,000.00
Jun 30, 2024 23,000.00
Mar 31, 2024 24,000.00
Mar 31, 2024 24,000.00
Dec 31, 2023 3.85 Mn
Dec 31, 2023 3.85 Mn